...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors.
【24h】

Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors.

机译:用慢病毒载体转导的小鼠造血干细胞的未改变重新预估性能。

获取原文
获取原文并翻译 | 示例

摘要

Recent studies of retroviral-mediated gene transfer have shown that retroviral integrations themselves may trigger nonmalignant clonal expansion of hematopoietic stem cells (HSCs) in transplant recipients. These observations suggested that previous conclusions of HSC dynamics based on gamma-retroviral gene marking should be confirmed with improved vectors having a more limited capacity to transactivate endogenous genes. Because of the low trans-activation activity of self-inactivating lentiviral vectors (LVs), we have investigated whether the LV marking of mouse HSCs induces a competitive repopulation advantage in recipients of serially transplants. As deduced from analyses conducted in primary and secondary recipients, we concluded that lentivirally transduced HSCs have no competitive repopulation advantages over untransduced HSCs. By linear amplification-mediated polymerase chain reaction (LAM-PCR) analysis, we characterized LV-targeted genes in HSC clones that engrafted up to quaternary recipients. Although 9 clones harbored integrations close to defined retroviral insertion sites, none was characterized as a common integration site, and none was present in HSC clones repopulating quaternary recipients. Taken together, our results show unaltered repopulation properties of HSCs transduced with LVs, and confirm early studies suggesting the natural capacity of a few HSC clones to generate a monoclonal or oligoclonal hematopoiesis in transplant recipients.
机译:最近对逆转录病毒介导的基因转移的研究表明,逆转录病毒整合本身可以在移植受者中引发造血干细胞(HSC)的非血管克隆膨胀。这些观察结果表明,基于γ-逆转录病毒基因标记的HSC动力学的先前结论应通过改进的载体来确认具有更有限的转移内源基因的容量。由于自灭活慢病毒载体(LVS)的低逆变活化活性,我们研究了小鼠HSC的LV标记是否在连续移植受体中引起竞争性重新迁移优势。从中发和次要受者进行的分析中推断出来,我们得出结论,慢病毒转导的HSCs对未经过度的HSCs没有竞争性的重新迁移优势。通过线性扩增介导的聚合酶链反应(LAM-PCR)分析,我们将植入季戊酯的HSC克隆中的LV靶向基因表征为季肾上腺素。虽然9个克隆近距离定义的逆转录病毒插入位点的覆盖集成,但没有表征为常见的集成站点,但HSC克隆中没有出现在第四纪接受者中的存在。我们的结果表明,用LVS转导的HSC的未改变重新掺杂性能,并确认早期研究表明少量HSC克隆的自然能力在移植受体中产生单克隆或寡核头血管缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号